Clinical Trials Directory

Trials / Completed

CompletedNCT02881268

Study of Immunosuppression Biomarkers Acquired in Patients Hospitalized in Intensive Care Unit

Status
Completed
Phase
Study type
Observational
Enrollment
44 (actual)
Sponsor
Rennes University Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Open-label, non-randomized, prospective, single center, observational, translational study

Detailed description

The aim of this trial is to study immunosuppression biomarkers in patients hospitalized in intensive care unit in comparison to non-septic patients. Prevalence of immunosuppression acquired in intensive care unit will be studied and patients most likely to develop nosocomial infection will be early identified

Conditions

Interventions

TypeNameDescription
OTHERblood sample

Timeline

Start date
2016-01-19
Primary completion
2021-01-14
Completion
2021-01-14
First posted
2016-08-26
Last updated
2022-01-19

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT02881268. Inclusion in this directory is not an endorsement.

Study of Immunosuppression Biomarkers Acquired in Patients Hospitalized in Intensive Care Unit (NCT02881268) · Clinical Trials Directory